GlobalData supported an Australian government healthcare organization by providing a comparative analysis of clinical trial performance among states in Australia.
The client approached GlobalData to produce a report comparing and analyzing the performance of clinical trials (between 2015-2018) and the commercial implications of such clinical trial activity and further comparing data and insights with other Australian states.
Our Solution
GlobalData leveraged its in-house proprietary data platform(s) and secondary market research in order get an understanding of clinical trials landscape for all states in Australia.
- Collected data on clinical trials (pharma and medical) conducted in Australia during 2015-2018.
- Total number of trials by state in Australia.
- Trials by Phase, status, top 5 therapy areas and indications.
- Analyzed publications on pre-clinical studies conducted in Australia during 2015-2018.
- Identified current and emerging Key Opinion Leaders (KOLs) in the states of Interest.
Outcome
GlobalData delivered an insightful report highlighting key insights on statistics and comparison of state level performance of clinical trials and publications on pre-clinical studies with rest of Australian states.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
